Tsimplouli C - Search Results

1

P90 ribosomal S6 kinases: A bona fide target for novel targeted anticancer therapies?

Koutsougianni F, Alexopoulou D, Uvez A, Lamprianidou A, Sereti E, Tsimplouli C, Ilkay Armutak E, Dimas K. Koutsougianni F, et al. Among authors: tsimplouli c. Biochem Pharmacol. 2023 Apr;210:115488. doi: 10.1016/j.bcp.2023.115488. Epub 2023 Mar 7. Biochem Pharmacol. 2023. PMID: 36889445 Review.

2

Study of the Relationship between Sigma Receptor Expression Levels and Some Common Sigma Ligand Activity in Cancer Using Human Cancer Cell Lines of the NCI-60 Cell Line Panel.

Sereti E, Tsimplouli C, Kalaitsidou E, Sakellaridis N, Dimas K. Sereti E, et al. Among authors: tsimplouli c. Biomedicines. 2021 Jan 5;9(1):38. doi: 10.3390/biomedicines9010038. Biomedicines. 2021. PMID: 33466391 Free PMC article.

3

A promising natural product, pristimerin, results in cytotoxicity against breast cancer stem cells in vitro and xenografts in vivo through apoptosis and an incomplete autopaghy in breast cancer.

Cevatemre B, Erkısa M, Aztopal N, Karakas D, Alper P, Tsimplouli C, Sereti E, Dimas K, Armutak EII, Gurevin EG, Uvez A, Mori M, Berardozzi S, Ingallina C, D'Acquarica I, Botta B, Ozpolat B, Ulukaya E. Cevatemre B, et al. Among authors: tsimplouli c. Pharmacol Res. 2018 Mar;129:500-514. doi: 10.1016/j.phrs.2017.11.027. Epub 2017 Dec 6. Pharmacol Res. 2018. PMID: 29197639

4

The labdane diterpene sclareol (labd-14-ene-8, 13-diol) induces apoptosis in human tumor cell lines and suppression of tumor growth in vivo via a p53-independent mechanism of action.

Mahaira LG, Tsimplouli C, Sakellaridis N, Alevizopoulos K, Demetzos C, Han Z, Pantazis P, Dimas K. Mahaira LG, et al. Among authors: tsimplouli c. Eur J Pharmacol. 2011 Sep;666(1-3):173-82. doi: 10.1016/j.ejphar.2011.04.065. Epub 2011 May 20. Eur J Pharmacol. 2011. PMID: 21620827

5

Potential of the dual mTOR kinase inhibitor AZD2014 to overcome paclitaxel resistance in anaplastic thyroid carcinoma.

Milošević Z, Banković J, Dinić J, Tsimplouli C, Sereti E, Dragoj M, Paunović V, Milovanović Z, Stepanović M, Tanić N, Dimas K, Pešić M. Milošević Z, et al. Among authors: tsimplouli c. Cell Oncol (Dordr). 2018 Aug;41(4):409-426. doi: 10.1007/s13402-018-0380-x. Epub 2018 May 22. Cell Oncol (Dordr). 2018. PMID: 29790111

6

In vitro activity of dietary flavonol congeners against human cancer cell lines.

Tsimplouli C, Demetzos C, Hadzopoulou-Cladaras M, Pantazis P, Dimas K. Tsimplouli C, et al. Eur J Nutr. 2012 Mar;51(2):181-90. doi: 10.1007/s00394-011-0204-5. Epub 2011 May 20. Eur J Nutr. 2012. PMID: 21598030

7

New chimeric advanced Drug Delivery nano Systems (chi-aDDnSs) as doxorubicin carriers.

Gardikis K, Tsimplouli C, Dimas K, Micha-Screttas M, Demetzos C. Gardikis K, et al. Among authors: tsimplouli c. Int J Pharm. 2010 Dec 15;402(1-2):231-7. doi: 10.1016/j.ijpharm.2010.10.007. Epub 2010 Oct 8. Int J Pharm. 2010. PMID: 20934501

8

The proteome profile of two cell lines and their xenografts isolated from a patient with clear cell sarcoma (soft tissue melanoma).

Dimas K, Tsimplouli C, Anagnostopoulos AK, Mahaira L, Iliopoulou E, Perez S, Vougas K, Tsangaris GT. Dimas K, et al. Among authors: tsimplouli c. Cancer Genomics Proteomics. 2008 May-Aug;5(3-4):175-237. Cancer Genomics Proteomics. 2008. PMID: 18820372 Free article.

9

Labd-14-ene-8,13-diol (sclareol) induces cell cycle arrest and apoptosis in human breast cancer cells and enhances the activity of anticancer drugs.

Dimas K, Papadaki M, Tsimplouli C, Hatziantoniou S, Alevizopoulos K, Pantazis P, Demetzos C. Dimas K, et al. Among authors: tsimplouli c. Biomed Pharmacother. 2006 Apr;60(3):127-33. doi: 10.1016/j.biopha.2006.01.003. Epub 2006 Feb 21. Biomed Pharmacother. 2006. PMID: 16527443

10

A new chimeric drug delivery nano system (chi-aDDnS) composed of PAMAM G 3.5 dendrimer and liposomes as doxorubicin's carrier. In vitro pharmacological studies.

Gardikis K, Fessas D, Signorelli M, Dimas K, Tsimplouli C, Ionov M, Demetzos C. Gardikis K, et al. Among authors: tsimplouli c. J Nanosci Nanotechnol. 2011 May;11(5):3764-72. doi: 10.1166/jnn.2011.3847. J Nanosci Nanotechnol. 2011. PMID: 21780367

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

12 results

Search Page